Your (or your loved one’s) medical records contain clues that can lead to new treatments.
AllStripes researchers learn from patient records what would truly improve quality of life.
Using cutting-edge tech we analyze your community’s data to improve trial design and chances of success.
Your community’s de-identified records can advance multiple treatment studies.
We do the work to collect all your records, at no cost, in your secure account. Access doctors’ notes you’ve never seen.
See how your rare disease journey compares to others with your condition, and what’s helping.
We’ll send you exclusive updates on the studies you’re contributing to and how you’re driving forward research.
Onno Faber (Founder) & Nancy Yu (CEO)
AllStripes’ mission is to empower patients and communities to accelerate drug development for rare diseases. About 1 in 10 people have a rare disease, and half are children.
AllStripes (formerly RDMD) was co-founded in 2017 by CEO Nancy Yu and Onno Faber, a rare disease patient deeply frustrated by the drug development process.
“I was diagnosed with a rare genetic disease and it completely changed my perspective,” Onno shares. “Patients can’t be bystanders in drug development.”
As the first and only research platform dedicated to rare diseases, AllStripes makes it easy for patients to contribute to new treatment studies from home. We do the work to collect and analyze your de-identified medical records to help power faster, better drug development for your condition.
The name AllStripes was inspired by the official symbol for the rare disease community, the zebra. When we come together and learn from each other’s experiences we can push for better treatments across all rare conditions.
We are determined to build a strong company around our mission, and be able to invest in as many diseases as we can to generate better outcomes for patients. We work as a team, help each other to be the best version or ourselves, promote open communication, learn from our mistakes, and do good in the world.
It’s official, RDMD has a new name: AllStripesPress Release,September 15, 2020
Digital Health 150: The Digital Health Startups Transforming The Future Of HealthcareCB Insights,August 13, 2020
100 of the Most Inspiring PeoplePharmaVOICE,August 1, 2020
Abundant funding, sparse data: San Francisco startup backs ‘real world’ model for rare disease drug developmentEndpoints News,April 16, 2020
RDMD Lands $14M to Expand Reach of Rare Disease Research PlatformXconomy,April 16, 2020